Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	chromatin binding	MLLT3 E2F4 TNRC18 ARID1B NKX6-1 BRD2 ATXN7 NFE2L1 AHDC1	1.50e-05	739	41	9	GO:0003682
GeneOntologyMolecularFunction	lysine-acetylated histone binding	MLLT3 BRD2 BRDT	3.14e-05	30	41	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	MLLT3 BRD2 BRDT	3.47e-05	31	41	3	GO:0140033
GeneOntologyMolecularFunction	modification-dependent protein binding	MLLT3 BRD2 BRDT HDGFL2	8.26e-04	206	41	4	GO:0140030
GeneOntologyMolecularFunction	histone reader activity	BRDT HDGFL2	1.30e-03	26	41	2	GO:0140566
GeneOntologyBiologicalProcess	tissue morphogenesis	CD44 DVL3 RBM15 LZTS2 BRD2 ALMS1 MICAL2 AHDC1 BRPF1	8.42e-06	750	39	9	GO:0048729
GeneOntologyBiologicalProcess	epithelial tube morphogenesis	CD44 DVL3 RBM15 LZTS2 BRD2 MICAL2 BRPF1	1.23e-05	421	39	7	GO:0060562
GeneOntologyBiologicalProcess	morphogenesis of an epithelium	CD44 DVL3 RBM15 LZTS2 BRD2 ALMS1 MICAL2 BRPF1	1.70e-05	619	39	8	GO:0002009
GeneOntologyBiologicalProcess	epithelium development	CD44 DVL3 RBM15 E2F4 NKX6-1 LZTS2 BRD2 ALMS1 NFE2L1 MICAL2 BRPF1	6.00e-05	1469	39	11	GO:0060429
GeneOntologyBiologicalProcess	animal organ morphogenesis	CD44 DVL3 RBM15 E2F4 FOXN3 NKX6-1 LZTS2 ALMS1 MICAL2 AHDC1	9.22e-05	1269	39	10	GO:0009887
GeneOntologyBiologicalProcess	chromatin organization	CHD9 MLLT3 RBM15 ARID1B BRD2 BRDT HDGFL2 BRPF1	2.28e-04	896	39	8	GO:0006325
GeneOntologyCellularComponent	nuclear speck	FAM193B DGKZ RBM15 PPIG BRD2 EAF2 PNN SRRM2	1.61e-06	431	41	8	GO:0016607
GeneOntologyCellularComponent	nuclear body	FAM193B DGKZ RBM15 PPIG BRD2 EAF2 PNN SRRM2 HSPB7 AFF3	7.12e-06	903	41	10	GO:0016604
GeneOntologyCellularComponent	super elongation complex	EAF2 AFF3	5.60e-05	6	41	2	GO:0032783
GeneOntologyCellularComponent	transcription elongation factor complex	MLLT3 EAF2 AFF3	1.81e-04	56	41	3	GO:0008023
GeneOntologyCellularComponent	chromatin	DVL3 E2F4 ARID1B FOXN3 NKX6-1 BRD2 BRDT ATXN7 NFE2L1 BRPF1	4.53e-04	1480	41	10	GO:0000785
HumanPheno	Delayed ability to walk	ARID1B ALMS1 SRRM2 AHDC1 BRPF1 RAI1	1.54e-05	304	11	6	HP:0031936
Domain	Bromodomain_CS	BRD2 BRDT BRPF1	2.46e-05	26	41	3	IPR018359
Domain	BET	BRD2 BRDT	2.81e-05	4	41	2	PF17035
Domain	NET_dom	BRD2 BRDT	2.81e-05	4	41	2	IPR027353
Domain	NET	BRD2 BRDT	2.81e-05	4	41	2	PS51525
Domain	BROMODOMAIN_1	BRD2 BRDT BRPF1	7.24e-05	37	41	3	PS00633
Domain	Bromodomain	BRD2 BRDT BRPF1	7.85e-05	38	41	3	PF00439
Domain	BROMODOMAIN_2	BRD2 BRDT BRPF1	9.88e-05	41	41	3	PS50014
Domain	BROMO	BRD2 BRDT BRPF1	1.06e-04	42	41	3	SM00297
Domain	Bromodomain	BRD2 BRDT BRPF1	1.06e-04	42	41	3	IPR001487
Domain	-	BRD2 BRDT BRPF1	1.06e-04	42	41	3	1.20.920.10
Domain	PWWP	HDGFL2 BRPF1	8.71e-04	20	41	2	SM00293
Domain	EPHD	BRPF1 RAI1	1.06e-03	22	41	2	PS51805
Domain	PWWP	HDGFL2 BRPF1	1.16e-03	23	41	2	PF00855
Domain	PWWP_dom	HDGFL2 BRPF1	1.16e-03	23	41	2	IPR000313
Domain	PWWP	HDGFL2 BRPF1	1.26e-03	24	41	2	PS50812
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	DVL3 CHD9 MLLT3 RBM15 PPIG IRS1 TNRC18 LZTS2 PNN SRRM2 MICAL2 AHDC1	1.29e-08	1247	41	12	27684187
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	CHD9 ARID1B LZTS2 BRD2 ALMS1 SRRM2 BRDT ATXN7 BRPF1 ARHGAP33 RAI1	4.62e-08	1116	41	11	31753913
Pubmed	The protein interaction landscape of the human CMGC kinase group.	MLLT3 RBM15 PPIG FOXN3 LZTS2 ALMS1 PNN SRRM2 AFF3	9.55e-08	695	41	9	23602568
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CHD9 TNRC18 FOXN3 LRFN2 LZTS2 ATXN7 MICAL2 AHDC1 RAI1 AFF3 WDR70	8.24e-07	1489	41	11	28611215
Pubmed	Over-expression of SR-cyclophilin, an interaction partner of nuclear pinin, releases SR family splicing factors from nuclear speckles.	PPIG PNN	1.36e-06	2	41	2	15358154
Pubmed	RNA-Binding Protein MEX3A Interacting with DVL3 Stabilizes Wnt/β-Catenin Signaling in Endometrial Carcinoma.	DVL3 MEX3A	1.36e-06	2	41	2	36614043
Pubmed	BS69/ZMYND11 reads and connects histone H3.3 lysine 36 trimethylation-decorated chromatin to regulated pre-mRNA processing.	PPIG PNN SRRM2	1.45e-06	19	41	3	25263594
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	CHD9 RBM15 PPIG ARID1B BRD2 PNN SRRM2 AHDC1 ARHGAP33	3.77e-06	1082	41	9	38697112
Pubmed	Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.	BRD2 BRDT	4.06e-06	3	41	2	28945351
Pubmed	SNX27-driven membrane localisation of OTULIN antagonises linear ubiquitination and NF-κB signalling activation.	DVL3 PHLPP1 DGKZ UBE2E1 BRD2 AHDC1	5.17e-06	378	41	6	34315543
Pubmed	RNF138 inhibits late inflammatory gene transcription through degradation of SMARCC1 of the SWI/SNF complex.	ARID1B UBE2E1 SRRM2	5.44e-06	29	41	3	36800290
Pubmed	Comprehensive Interactome Mapping of the DNA Repair Scaffold SLX4 Using Proximity Labeling and Affinity Purification.	CHD9 RBM15 BRD2 ATXN7 AFF3	6.29e-06	222	41	5	37071664
Pubmed	A novel IRS-1-associated protein, DGKζ regulates GLUT4 translocation in 3T3-L1 adipocytes.	DGKZ IRS1	8.12e-06	4	41	2	27739494
Pubmed	Pinin/DRS/memA interacts with SRp75, SRm300 and SRrp130 in corneal epithelial cells.	PNN SRRM2	8.12e-06	4	41	2	14578391
Pubmed	Expression of BET genes in testis of men with different spermatogenic impairments.	BRD2 BRDT	8.12e-06	4	41	2	22035730
Pubmed	ATXN3, ATXN7, CACNA1A, and RAI1 Genes and Mitochondrial Polymorphism A10398G Did Not Modify Age at Onset in Spinocerebellar Ataxia Type 2 Patients from South America.	ATXN7 RAI1	8.12e-06	4	41	2	25869926
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	CD44 RBM15 PPIG BRD2 PNN SRRM2 HDGFL2	1.10e-05	660	41	7	32780723
Pubmed	Proximity-dependent Mapping of the Androgen Receptor Identifies Kruppel-like Factor 4 as a Functional Partner.	TNRC18 ARID1B PNN AHDC1 RAI1	1.56e-05	268	41	5	33640491
Pubmed	Oncogenic ZMYND11-MBTD1 fusion protein anchors the NuA4/TIP60 histone acetyltransferase complex to the coding region of active genes.	PPIG PNN SRRM2	1.69e-05	42	41	3	35705031
Pubmed	Structural and histone binding ability characterizations of human PWWP domains.	HDGFL2 BRPF1	2.03e-05	6	41	2	21720545
Pubmed	Synthetic Lethal and Resistance Interactions with BET Bromodomain Inhibitors in Triple-Negative Breast Cancer.	CHD9 RBM15 PPIG UBE2E1 BRD2 PNN HDGFL2 WDR70	2.06e-05	1014	41	8	32416067
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CD44 PHLPP1 RBM15 ARID1B LZTS2 FCHO2 BRD2 SRRM2	2.63e-05	1049	41	8	27880917
Pubmed	Transcriptomic analysis of PNN- and ESRP1-regulated alternative pre-mRNA splicing in human corneal epithelial cells.	CD44 PNN	2.84e-05	7	41	2	23299472
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	RBM15 PPIG BRD2 PNN SRRM2 ATXN7 BRPF1	3.06e-05	774	41	7	15302935
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FAM193B IRS1 TNRC18 BRD2 AHDC1 ARHGAP33 RAI1 WDR70	3.81e-05	1105	41	8	35748872
Pubmed	The RNA binding protein MEX3A promotes tumor progression of breast cancer by post-transcriptional regulation of IGFBP4.	TNRC18 MEX3A NFE2L1 AHDC1 BRPF1	4.35e-05	332	41	5	37433992
Pubmed	MYC Protein Interactome Profiling Reveals Functionally Distinct Regions that Cooperate to Drive Tumorigenesis.	ARID1B BRD2 PNN ATXN7 NFE2L1	4.80e-05	339	41	5	30415952
Pubmed	Negative Feedback Loop Mechanism between EAF1/2 and DBC1 in Regulating ELL Stability and Functions.	MLLT3 EAF2	4.86e-05	9	41	2	36036574
Pubmed	Interaction network of human early embryonic transcription factors.	TNRC18 ARID1B ALMS1 AHDC1 RAI1	5.66e-05	351	41	5	38297188
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RBM15 PPIG PNN SRRM2 WDR70	6.46e-05	361	41	5	26167880
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RBM15 BRD2 PNN SRRM2 HDGFL2 RAI1	7.24e-05	605	41	6	28977666
Pubmed	Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.	EPHB6 FAM193B TNRC18 LZTS2 BRD2 AHDC1 DBNDD2 AFF3	7.42e-05	1215	41	8	15146197
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	CHD9 BRD2 HDGFL2 BRPF1 RAI1 WDR70	7.44e-05	608	41	6	36089195
Pubmed	The little elongation complex regulates small nuclear RNA transcription.	MLLT3 EAF2	8.88e-05	12	41	2	22195968
Pubmed	Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination.	BRD2 BRDT BRPF1	9.68e-05	75	41	3	25593309
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	RBM15 ARID1B BRD2 PNN SRRM2 HDGFL2 RAI1	1.14e-04	954	41	7	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RBM15 PPIG BRD2 PNN SRRM2 HDGFL2 AHDC1 RAI1	1.15e-04	1294	41	8	30804502
Pubmed	MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia.	MLLT3 AFF3	1.22e-04	14	41	2	20854876
Pubmed	Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control.	E2F4 ARID1B	1.41e-04	15	41	2	17255939
Pubmed	Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS.	MLLT3 BRD2 PNN HDGFL2 AFF3	1.50e-04	432	41	5	23455922
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	RBM15 PNN SRRM2 BRPF1	1.66e-04	234	41	4	36243803
Pubmed	A multipotent progenitor domain guides pancreatic organogenesis.	NKX6-1 BRD2 BRPF1	1.72e-04	91	41	3	17609113
Pubmed	E2F6 associates with BRG1 in transcriptional regulation.	E2F4 BRDT	1.82e-04	17	41	2	23082233
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DVL3 MLLT3 DGKZ LZTS2 FCHO2 EAF2 WDR70	1.91e-04	1038	41	7	26673895
Pubmed	Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.	EPHB6 IRS1 ARID1B BRD2 BRDT NFE2L1	2.01e-04	730	41	6	34857952
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	RBM15 PPIG BRD2 HDGFL2	2.17e-04	251	41	4	31076518
Pubmed	Dynamic Protein Interactions of the Polycomb Repressive Complex 2 during Differentiation of Pluripotent Cells.	BRD2 ALMS1 ZCCHC10 HDGFL2 AHDC1	2.19e-04	469	41	5	27634302
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	CD44 ARID1B FCHO2 SRRM2 HDGFL2	2.26e-04	472	41	5	38943005
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	PPIG IRS1 PNN SRRM2	2.31e-04	255	41	4	15324660
Pubmed	Identification of Human Neuronal Protein Complexes Reveals Biochemical Activities and Convergent Mechanisms of Action in Autism Spectrum Disorders.	PPIG LZTS2 PNN	2.34e-04	101	41	3	26949739
Pubmed	SNIP1 Recruits TET2 to Regulate c-MYC Target Genes and Cellular DNA Damage Response.	PPIG PNN SRRM2 RAI1	2.45e-04	259	41	4	30404004
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	BRD2 PNN RAI1	2.48e-04	103	41	3	32744500
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	CHD9 ALMS1 SRRM2	2.55e-04	104	41	3	9205841
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	DVL3 LZTS2 ALMS1 PNN	2.60e-04	263	41	4	34702444
Pubmed	Prediction of the coding sequences of unidentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	TNRC18 LZTS2 RAI1	2.77e-04	107	41	3	11347906
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	CHD9 RBM15 TNRC18 ARID1B SRRM2 AHDC1 RAI1	2.77e-04	1103	41	7	34189442
Pubmed	T-Box transcription factor Tbx20 regulates a genetic program for cranial motor neuron cell body migration.	DVL3 NKX6-1	2.81e-04	21	41	2	17119020
Pubmed	Impaired plasma membrane localization of ubiquitin ligase complex underlies 3-M syndrome development.	DVL3 EPHB6 RBM15 BRDT AFF3	2.84e-04	496	41	5	31343991
Pubmed	Interaction proteome of human Hippo signaling: modular control of the co-activator YAP1.	DVL3 MLLT3 PNN SRRM2	2.87e-04	270	41	4	24366813
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	CHD9 TNRC18 NFE2L1	3.01e-04	110	41	3	26841866
Pubmed	Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.	CHD9 PNN DBNDD2	3.79e-04	119	41	3	10931946
Pubmed	Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains.	CHD9 BRD2 PNN SRRM2 BRDT	3.94e-04	533	41	5	30554943
Pubmed	Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.	ATXN7 HDGFL2 AHDC1	4.27e-04	124	41	3	20850016
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	LZTS2 FCHO2 SRRM2	4.37e-04	125	41	3	29467281
Pubmed	JMJD1C Exhibits Multiple Functions in Epigenetic Regulation during Spermatogenesis.	BCL6B BRDT	5.39e-04	29	41	2	27649575
Pubmed	An embryonic stem cell chromatin remodeling complex, esBAF, is essential for embryonic stem cell self-renewal and pluripotency.	ARID1B SRRM2	5.39e-04	29	41	2	19279220
Pubmed	A census of human transcription factors: function, expression and evolution.	BCL6B MLLT3 E2F4 FOXN3 NKX6-1 NFE2L1	6.42e-04	908	41	6	19274049
Pubmed	DBC1, p300, HDAC3, and Siah1 coordinately regulate ELL stability and function for expression of its target genes.	MLLT3 EAF2	7.43e-04	34	41	2	32152128
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	ARID1B BRD2 HDGFL2	7.43e-04	150	41	3	28242625
Pubmed	BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression.	DVL3 RBM15 PPIG UBE2E1 ZCCHC10 PNN SRRM2	8.03e-04	1318	41	7	30463901
Pubmed	MKRN2 Physically Interacts with GLE1 to Regulate mRNA Export and Zebrafish Retinal Development.	PPIG MEX3A PNN SRRM2	8.28e-04	358	41	4	32460013
Pubmed	Targeted ubiquitination and degradation of G-protein-coupled receptor kinase 5 by the DDB1-CUL4 ubiquitin ligase complex.	PPIG PNN SRRM2	8.33e-04	156	41	3	22952844
Pubmed	Sufu- and Spop-mediated downregulation of Hedgehog signaling promotes beta cell differentiation through organ-specific niche signals.	CD44 NKX6-1	8.33e-04	36	41	2	31604927
Pubmed	The Epigenetic Factor Landscape of Developing Neocortex Is Regulated by Transcription Factors Pax6→ Tbr2→ Tbr1.	MLLT3 ARID1B BRPF1	8.48e-04	157	41	3	30186101
Pubmed	A protein interaction landscape of breast cancer.	E2F4 IRS1 ARID1B LZTS2 MICAL2	8.63e-04	634	41	5	34591612
Pubmed	USP1 deubiquitinates Akt to inhibit PI3K-Akt-FoxO signaling in muscle during prolonged starvation.	PHLPP1 FCHO2	8.80e-04	37	41	2	32133736
Pubmed	A bead-based approach for large-scale identification of in vitro kinase substrates.	PNN SRRM2 HDGFL2	9.45e-04	163	41	3	22113938
Pubmed	LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.	DGKZ MEX3A MICAL2	1.03e-03	168	41	3	30631154
Pubmed	Proximity interactions of the ubiquitin ligase Mind bomb 1 reveal a role in regulation of epithelial polarity complex proteins.	E2F4 FCHO2 PNN	1.05e-03	169	41	3	31462741
Pubmed	Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells.	PPIG BRD2 PNN SRRM2 HDGFL2	1.07e-03	665	41	5	30457570
Pubmed	Characterization of the DOT1L network: implications of diverse roles for DOT1L.	MLLT3 AFF3	1.08e-03	41	41	2	20431927
Interaction	PIP4K2A interactions	CHD9 MLLT3 PPIG LZTS2 BRD2 EAF2 ZCCHC10 PNN SRRM2 HDGFL2 BRPF1 AFF3	1.02e-14	216	41	12	int:PIP4K2A
Interaction	NFKBIL1 interactions	CHD9 PPIG TNRC18 BRD2 ZCCHC10 PNN SRRM2 HDGFL2	1.28e-11	93	41	8	int:NFKBIL1
Interaction	CAMKV interactions	CD44 CHD9 MLLT3 TNRC18 BRD2 ZCCHC10 PNN SRRM2	8.83e-11	118	41	8	int:CAMKV
Interaction	MDK interactions	CHD9 MLLT3 PPIG TNRC18 BRD2 PNN SRRM2	6.01e-10	91	41	7	int:MDK
Interaction	DAXX interactions	CHD9 MLLT3 TNRC18 MEX3A BRD2 ZCCHC10 PNN SRRM2 HDGFL2 RAI1	1.66e-09	353	41	10	int:DAXX
Interaction	SYT2 interactions	CHD9 MLLT3 EAF2 HDGFL2 BRPF1 AFF3 WDR70	2.00e-08	150	41	7	int:SYT2
Interaction	EPB41L3 interactions	CD44 CHD9 MLLT3 PPIG TNRC18 ZCCHC10 PNN SRRM2	6.45e-08	272	41	8	int:EPB41L3
Interaction	BRD9 interactions	ARID1B BRD2 ZCCHC10 PNN SRRM2 NFE2L1	1.28e-07	117	41	6	int:BRD9
Interaction	SULF2 interactions	CHD9 MLLT3 TNRC18 BRD2 ZCCHC10 SRRM2	1.42e-07	119	41	6	int:SULF2
Interaction	PLCD3 interactions	CHD9 MLLT3 BRD2 ZCCHC10 HDGFL2 WDR70	1.57e-07	121	41	6	int:PLCD3
Interaction	RNF151 interactions	DVL3 MLLT3 PPIG TNRC18 PNN SRRM2	1.73e-07	123	41	6	int:RNF151
Interaction	NKAP interactions	CHD9 PPIG BRD2 ZCCHC10 PNN SRRM2	2.62e-07	132	41	6	int:NKAP
Interaction	DDX23 interactions	RBM15 PPIG BRD2 PNN SRRM2 BRDT HDGFL2 BRPF1 WDR70	4.07e-07	480	41	9	int:DDX23
Interaction	VANGL1 interactions	CD44 DVL3 PHLPP1 BRD2 ZCCHC10 PNN HDGFL2	4.18e-07	234	41	7	int:VANGL1
Interaction	DENND2D interactions	MLLT3 BRD2 PNN SRRM2	8.28e-07	36	41	4	int:DENND2D
Interaction	PIP4K2B interactions	LZTS2 BRD2 ZCCHC10 HDGFL2 HSPB7	1.44e-06	96	41	5	int:PIP4K2B
Interaction	PPIE interactions	DVL3 CHD9 E2F4 ZCCHC10 PNN SRRM2 WDR70	1.46e-06	282	41	7	int:PPIE
Interaction	AKAP17A interactions	DVL3 BRD2 ZCCHC10 PNN SRRM2	1.68e-06	99	41	5	int:AKAP17A
Interaction	PTPN3 interactions	DGKZ LZTS2 ZCCHC10 SRRM2 WDR70	1.77e-06	100	41	5	int:PTPN3
Interaction	VANGL2 interactions	CD44 DVL3 BRD2 ZCCHC10 PNN HDGFL2	1.90e-06	185	41	6	int:VANGL2
Interaction	EPB41L1 interactions	MLLT3 TNRC18 BRD2 ZCCHC10 PNN SRRM2	2.02e-06	187	41	6	int:EPB41L1
Interaction	BTRC interactions	PHLPP1 E2F4 IRS1 FOXN3 LZTS2 BRD2 ALMS1 PNN NFE2L1 HDGFL2	2.53e-06	775	41	10	int:BTRC
Interaction	SRSF11 interactions	PHLPP1 PPIG E2F4 ZCCHC10 PNN SRRM2	3.25e-06	203	41	6	int:SRSF11
Interaction	POLR1G interactions	CHD9 E2F4 LZTS2 BRD2 SRRM2 BRPF1 RAI1 WDR70	5.36e-06	489	41	8	int:POLR1G
Interaction	SRRM1 interactions	E2F4 BRD2 ZCCHC10 PNN SRRM2 BRDT WDR70	5.85e-06	348	41	7	int:SRRM1
Interaction	PRPF38A interactions	DVL3 PPIG E2F4 ZCCHC10 WDR70	1.82e-05	161	41	5	int:PRPF38A
Interaction	SNIP1 interactions	DVL3 PPIG ARID1B BRD2 ZCCHC10 PNN SRRM2	1.89e-05	417	41	7	int:SNIP1
Interaction	RASA2 interactions	MLLT3 HDGFL2 WDR70	1.97e-05	26	41	3	int:RASA2
Interaction	EPB41L2 interactions	PHLPP1 MLLT3 PPIG ARID1B PNN SRRM2	2.95e-05	299	41	6	int:EPB41L2
Interaction	MAB21L3 interactions	DVL3 LZTS2 ZCCHC10	3.05e-05	30	41	3	int:MAB21L3
Interaction	ARRB2 interactions	MLLT3 DGKZ BRD2 SRRM2 HDGFL2 BRPF1 WDR70	3.26e-05	454	41	7	int:ARRB2
Interaction	GTF3C6 interactions	CD44 ZCCHC10 SRRM2	3.38e-05	31	41	3	int:GTF3C6
Interaction	XAB2 interactions	CD44 DVL3 E2F4 ZCCHC10 PNN	3.63e-05	186	41	5	int:XAB2
Interaction	PLCD4 interactions	MLLT3 BRPF1 WDR70	3.72e-05	32	41	3	int:PLCD4
Interaction	GSK3A interactions	FAM193B TNRC18 LZTS2 ALMS1 PNN SRRM2 AHDC1	3.74e-05	464	41	7	int:GSK3A
Interaction	BEND7 interactions	DVL3 PPIG EAF2 ZCCHC10	3.94e-05	94	41	4	int:BEND7
Interaction	NUMA1 interactions	DVL3 MEX3A BRD2 PNN BRDT BRPF1 RAI1	4.01e-05	469	41	7	int:NUMA1
Interaction	CCDC12 interactions	DVL3 E2F4 LZTS2 ZCCHC10	5.85e-05	104	41	4	int:CCDC12
Interaction	SSRP1 interactions	RBM15 E2F4 BRD2 PNN SRRM2 HDGFL2 BRPF1 RAI1	6.05e-05	685	41	8	int:SSRP1
Interaction	MED26 interactions	MLLT3 BRD2 EAF2 ZCCHC10	6.54e-05	107	41	4	int:MED26
Interaction	SMARCA2 interactions	ARID1B BRD2 ZCCHC10 SRRM2 HDGFL2 ARHGAP33	6.64e-05	346	41	6	int:SMARCA2
Interaction	PDAP1 interactions	PHLPP1 CHD9 E2F4 RAI1	6.78e-05	108	41	4	int:PDAP1
Interaction	AMPD2 interactions	CD44 LZTS2 BRD2 HDGFL2	6.78e-05	108	41	4	int:AMPD2
Interaction	SMARCD1 interactions	ARID1B LZTS2 BRD2 ZCCHC10 BRDT HDGFL2	6.97e-05	349	41	6	int:SMARCD1
Interaction	CLK1 interactions	DVL3 RBM15 PPIG PNN SRRM2	7.89e-05	219	41	5	int:CLK1
Interaction	EDA interactions	MLLT3 TNRC18 PNN SRRM2	8.09e-05	113	41	4	int:EDA
Interaction	RSBN1L interactions	BRD2 ZCCHC10 PNN SRRM2	8.37e-05	114	41	4	int:RSBN1L
Interaction	CSNK2A2 interactions	DGKZ IRS1 BRD2 PNN SRRM2 BRDT HDGFL2 BRPF1	8.41e-05	718	41	8	int:CSNK2A2
Interaction	CSNK2A1 interactions	DVL3 DGKZ E2F4 IRS1 BRD2 ZCCHC10 PNN SRRM2 HDGFL2	1.04e-04	956	41	9	int:CSNK2A1
Interaction	NOG interactions	BRD2 PNN SRRM2	1.05e-04	45	41	3	int:NOG
Interaction	COIL interactions	CHD9 MLLT3 RBM15 E2F4 BRD2 ZCCHC10 BRPF1	1.12e-04	552	41	7	int:COIL
Interaction	MLLT1 interactions	MLLT3 ARID1B HDGFL2 AFF3	1.12e-04	123	41	4	int:MLLT1
Interaction	SMARCC1 interactions	E2F4 ARID1B BRD2 SRRM2 BRDT HDGFL2	1.18e-04	384	41	6	int:SMARCC1
Interaction	MEX3A interactions	DVL3 TNRC18 MEX3A NFE2L1 AHDC1 BRPF1	1.18e-04	384	41	6	int:MEX3A
Interaction	MYH9 interactions	CD44 PHLPP1 CHD9 TNRC18 MEX3A LZTS2 FCHO2 AHDC1	1.18e-04	754	41	8	int:MYH9
Interaction	TAF8 interactions	BRD2 ZCCHC10 BRDT	1.43e-04	50	41	3	int:TAF8
Interaction	CEBPA interactions	CHD9 RBM15 E2F4 TNRC18 ARID1B PNN SRRM2 HDGFL2 AHDC1 RAI1	1.50e-04	1245	41	10	int:CEBPA
Interaction	ISY1 interactions	CD44 DVL3 ZCCHC10 PNN	1.61e-04	135	41	4	int:ISY1
Interaction	H1-0 interactions	E2F4 UBE2E1 BRD2 BRDT RAI1	1.64e-04	256	41	5	int:H1-0
Interaction	PES1 interactions	MLLT3 TNRC18 BRD2 PNN SRRM2	1.70e-04	258	41	5	int:PES1
Interaction	CEP70 interactions	DVL3 PPIG ZCCHC10 ATXN7 BRPF1	1.83e-04	262	41	5	int:CEP70
Interaction	KIF23 interactions	CD44 PHLPP1 CHD9 PPIG TNRC18 ALMS1 PNN SRRM2 MICAL2	1.84e-04	1031	41	9	int:KIF23
Interaction	DAB2 interactions	DVL3 PHLPP1 FCHO2 HDGFL2	1.85e-04	140	41	4	int:DAB2
Interaction	PABPC5 interactions	EPHB6 PPIG PNN SRRM2	1.95e-04	142	41	4	int:PABPC5
Interaction	FAM9A interactions	MLLT3 PNN SRRM2	2.35e-04	59	41	3	int:FAM9A
Interaction	NUP43 interactions	CHD9 RBM15 E2F4 ARID1B PNN SRRM2 AHDC1	2.40e-04	625	41	7	int:NUP43
Interaction	CSNK2B interactions	DGKZ E2F4 IRS1 BRD2 BRDT HDGFL2 BRPF1	2.40e-04	625	41	7	int:CSNK2B
Interaction	ANKRD36B interactions	DVL3 CHD9 ZCCHC10	2.47e-04	60	41	3	int:ANKRD36B
Interaction	SLU7 interactions	PPIG LZTS2 ZCCHC10 SRRM2	2.80e-04	156	41	4	int:SLU7
Interaction	TCEA2 interactions	DVL3 LZTS2 EAF2 PNN	3.01e-04	159	41	4	int:TCEA2
Interaction	PIP4K2C interactions	LZTS2 BRD2 ZCCHC10 HDGFL2	3.01e-04	159	41	4	int:PIP4K2C
Interaction	RAD18 interactions	CD44 RBM15 PPIG BRD2 SRRM2 HDGFL2	3.02e-04	457	41	6	int:RAD18
Interaction	NKAPD1 interactions	PPIG ZCCHC10 PNN SRRM2	3.16e-04	161	41	4	int:NKAPD1
Interaction	SMARCA4 interactions	E2F4 ARID1B MEX3A BRD2 SRRM2 BRDT	3.20e-04	462	41	6	int:SMARCA4
Interaction	EPB41L5 interactions	CHD9 MLLT3 BRD2 ZCCHC10 PNN	3.31e-04	298	41	5	int:EPB41L5
Interaction	BICRA interactions	ARID1B BRD2 ZCCHC10	3.42e-04	67	41	3	int:BICRA
Interaction	PNN interactions	PPIG BRD2 PNN SRRM2 BRDT	3.52e-04	302	41	5	int:PNN
Interaction	C1orf35 interactions	DVL3 CHD9 BRD2 PNN SRRM2	3.63e-04	304	41	5	int:C1orf35
Interaction	SAP18 interactions	PPIG E2F4 BRD2 PNN SRRM2	3.68e-04	305	41	5	int:SAP18
Interaction	SARNP interactions	PPIG E2F4 PNN SRRM2	3.71e-04	168	41	4	int:SARNP
Interaction	FIBP interactions	LZTS2 BRD2 ZCCHC10	3.73e-04	69	41	3	int:FIBP
Interaction	NUPR1 interactions	CD44 RBM15 PPIG BRD2 PNN SRRM2 HDGFL2	4.10e-04	683	41	7	int:NUPR1
Interaction	ERCC3 interactions	LZTS2 BRD2 ZCCHC10 BRDT	4.33e-04	175	41	4	int:ERCC3
Interaction	RBM15 interactions	PHLPP1 RBM15 E2F4 LZTS2	4.33e-04	175	41	4	int:RBM15
Interaction	CRNKL1 interactions	DVL3 LZTS2 ZCCHC10 PNN	4.52e-04	177	41	4	int:CRNKL1
Interaction	WDR48 interactions	PHLPP1 FCHO2 BRD2 WDR70	4.52e-04	177	41	4	int:WDR48
Interaction	H2BC21 interactions	ARID1B BRD2 ZCCHC10 PNN SRRM2 BRPF1 RAI1	4.59e-04	696	41	7	int:H2BC21
Interaction	CEP63 interactions	LZTS2 ALMS1 ZCCHC10 BRPF1	4.72e-04	179	41	4	int:CEP63
Interaction	AFF3 interactions	MLLT3 AFF3	4.76e-04	16	41	2	int:AFF3
Interaction	VAX1 interactions	DVL3 MLLT3	4.76e-04	16	41	2	int:VAX1
Interaction	EAPP interactions	LZTS2 ZCCHC10 SRRM2	4.96e-04	76	41	3	int:EAPP
Interaction	UBN1 interactions	E2F4 MEX3A ZCCHC10	5.15e-04	77	41	3	int:UBN1
Interaction	CHD4 interactions	MLLT3 RBM15 MEX3A BRD2 PNN SRRM2 HDGFL2 RAI1	5.19e-04	938	41	8	int:CHD4
Interaction	HP1BP3 interactions	E2F4 BRD2 BRDT BRPF1 WDR70	5.20e-04	329	41	5	int:HP1BP3
Interaction	PRP4K interactions	E2F4 BRD2 ZCCHC10 PNN SRRM2	5.20e-04	329	41	5	int:PRP4K
Interaction	BRPF1 interactions	MEX3A BRD2 BRPF1	5.35e-04	78	41	3	int:BRPF1
Interaction	CT45A5 interactions	CHD9 MLLT3 BRD2	5.35e-04	78	41	3	int:CT45A5
Interaction	SNX27 interactions	DVL3 PHLPP1 DGKZ UBE2E1 BRD2 AHDC1	5.35e-04	509	41	6	int:SNX27
Interaction	NOVA2 interactions	BRD2 BRDT	5.39e-04	17	41	2	int:NOVA2
Interaction	SRPK2 interactions	RBM15 PPIG FOXN3 ALMS1 PNN SRRM2 WDR70	5.48e-04	717	41	7	int:SRPK2
GeneFamily	AF4/FMR2 family\|Super elongation complex	MLLT3 AFF3	8.88e-05	9	29	2	1280
Coexpression	GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_UP	CD44 DVL3 PHLPP1 DBNDD2 AFF3	6.52e-06	169	41	5	M8940
Coexpression	MIYAGAWA_TARGETS_OF_EWSR1_ETS_FUSIONS_DN	CD44 IRS1 MICAL2 HSPB7 AFF3	3.20e-05	235	41	5	M2256
Coexpression	UDAYAKUMAR_MED1_TARGETS_DN	PHLPP1 BRD2 PNN NFE2L1 HSPB7	3.82e-05	244	41	5	M9945
Coexpression	DAZARD_UV_RESPONSE_CLUSTER_G6	PHLPP1 CHD9 IRS1 MICAL2	7.76e-05	145	41	4	M1810
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	PHLPP1 CHD9 IRS1 MICAL2 AHDC1	1.02e-04	300	41	5	M8702
Coexpression	GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN	DGKZ BRD2 PNN ATXN7	1.94e-04	184	41	4	M19988
Coexpression	GSE25088_CTRL_VS_IL4_STIM_MACROPHAGE_UP	BCL6B MLLT3 FOXN3 UBE2E1	2.43e-04	195	41	4	M8006
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE	PPIG ZCCHC10 PNN ATXN7 AFF3	2.47e-04	363	41	5	M41103
Coexpression	GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN	CD44 MICAL2 BRPF1 RAI1	2.52e-04	197	41	4	M7921
Coexpression	GSE22886_NAIVE_CD4_TCELL_VS_12H_ACT_TH1_UP	CD44 DGKZ ATXN7 ARHGAP33	2.62e-04	199	41	4	M4521
Coexpression	GSE7548_NAIVE_VS_DAY28_PCC_IMMUNIZATION_CD4_TCELL_UP	PPIG PNN SRRM2 ARHGAP33	2.62e-04	199	41	4	M6839
Coexpression	GSE21670_TGFB_VS_IL6_TREATED_STAT3_KO_CD4_TCELL_UP	BCL6B CHD9 BRD2 DBNDD2	2.62e-04	199	41	4	M7448
Coexpression	GSE39820_CTRL_VS_TGFBETA1_IL6_IL23A_CD4_TCELL_UP	RBM15 FOXN3 PNN SRRM2	2.62e-04	199	41	4	M5607
Coexpression	GSE14308_TH17_VS_NATURAL_TREG_DN	BCL6B CHD9 DGKZ TNRC18	2.67e-04	200	41	4	M3390
Coexpression	GSE23984_CTRL_VS_HYPOCALEMIC_VITAMIND_ANALOG_TCELL_DN	PHLPP1 FOXN3 SRRM2 ATXN7	2.67e-04	200	41	4	M8052
Coexpression	GSE28737_BCL6_HET_VS_BCL6_KO_FOLLICULAR_BCELL_UP	CD44 DGKZ BRDT MICAL2	2.67e-04	200	41	4	M9380
Coexpression	GSE9037_CTRL_VS_LPS_4H_STIM_BMDM_DN	BCL6B PPIG BRD2 ATXN7	2.67e-04	200	41	4	M5806
Coexpression	GSE14350_IL2RB_KO_VS_WT_TEFF_UP	FOXN3 NKX6-1 DBNDD2 AFF3	2.67e-04	200	41	4	M3423
Coexpression	GSE17186_BLOOD_VS_CORD_BLOOD_NAIVE_BCELL_UP	CD44 UBE2E1 ALMS1 DBNDD2	2.67e-04	200	41	4	M7194
Coexpression	GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_DN	CD44 ARID1B BRD2 EAF2	2.67e-04	200	41	4	M8691
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPIG FOXN3 BRD2 SRRM2 ATXN7	7.80e-07	187	41	5	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	EPHB6 CHD9 MLLT3 FOXN3 MEX3A	9.84e-07	196	41	5	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	EPHB6 CHD9 MLLT3 FOXN3 MEX3A	9.84e-07	196	41	5	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Tracheal-NucSeq\|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations	MLLT3 ARID1B FOXN3 AFF3 WDR70	1.06e-06	199	41	5	94b94b17ca18b8dc27b91da1f2ccf89e03cc7035
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	ARID1B FOXN3 BRD2 PNN SRRM2	1.09e-06	200	41	5	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	severe-unassigned\|World / disease stage, cell group and cell class	DVL3 MEX3A LZTS2 HDGFL2	1.55e-05	164	41	4	b3a45c150df6594debeeca400cc58d30ef662756
ToppCell	severe-unassigned\|severe / disease stage, cell group and cell class	DVL3 MEX3A LZTS2 HDGFL2	1.59e-05	165	41	4	f9ddd547992fec065d539a1d0305acba8fc7d79c
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PPIG FOXN3 BRD2 SRRM2	2.65e-05	188	41	4	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRS1 ARID1B FOXN3 EAF2	2.82e-05	191	41	4	4aa29337f4d2528577bb90dc4abfb6eab93e120f
ToppCell	facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRS1 ARID1B FOXN3 EAF2	2.82e-05	191	41	4	318323a12029a7992f16382cb0c186f5b2e1ca47
ToppCell	Mild/Remission-B_naive-8\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	ARID1B PNN AHDC1 AFF3	3.06e-05	195	41	4	0a3221e4d1fa31a35868bdda0f0cc873c233b407
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	MLLT3 ARID1B AFF3 WDR70	3.12e-05	196	41	4	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID1B FOXN3 PNN SRRM2	3.18e-05	197	41	4	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID1B FOXN3 PNN SRRM2	3.24e-05	198	41	4	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID1B FOXN3 PNN SRRM2	3.24e-05	198	41	4	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Mild/Remission-B_naive-9\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	EAF2 ZCCHC10 PNN AFF3	3.31e-05	199	41	4	e9af3c6a05f435ac8d7066f54feb653012b51ffb
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	ARID1B BRD2 PNN AFF3	3.31e-05	199	41	4	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	control-Epithelial-Secretory\|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	CD44 CHD9 FOXN3 PNN	3.31e-05	199	41	4	3d01f90ffd271ca00129192787e4921bdca7e01e
Drug	p-hydroxymandelonitrile	DVL3 EPHB6 MLLT3 AHDC1 AFF3	2.13e-06	117	41	5	CID000166768
Drug	Chloroprene	BCL6B MLLT3 DGKZ PPIG IRS1 ARID1B PNN SRRM2 ATXN7 MICAL2 HSPB7 AFF3	2.80e-06	1348	41	12	ctd:D002737
Drug	radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	FAM193B FOXN3 ALMS1 MICAL2 BRPF1	2.31e-05	191	41	5	1057_DN
Drug	Cyclosporin A [59865-13-3]; Down 200; 3.4uM; PC3; HT_HG-U133A	CD44 DVL3 E2F4 FOXN3 SRRM2	2.62e-05	196	41	5	4586_DN
Drug	LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A	CD44 FAM193B ALMS1 ATXN7 ARHGAP33	2.75e-05	198	41	5	6976_UP
Drug	leukotoxin B (12,13-EODE); Down 200; 0.2uM; MCF7; HT_HG-U133A_EA	CD44 MLLT3 FAM193B ALMS1 NFE2L1	2.81e-05	199	41	5	1108_DN
Drug	2-propylpentanoic acid; Down 200; 200uM; PC3; HT_HG-U133A	E2F4 ALMS1 ATXN7 MICAL2 ARHGAP33	2.81e-05	199	41	5	4438_DN
Drug	AC1L3UEY	PHLPP1 PPIG PNN AHDC1	5.06e-05	113	41	4	CID000122342
Disease	Arsenic Induced Polyneuropathy	CD44 UBE2E1 ATXN7	8.90e-05	62	41	3	C0751852
Disease	Arsenic Encephalopathy	CD44 UBE2E1 ATXN7	8.90e-05	62	41	3	C0751851
Disease	Arsenic Poisoning	CD44 UBE2E1 ATXN7	8.90e-05	62	41	3	C0311375
Disease	Arsenic Poisoning, Inorganic	CD44 UBE2E1 ATXN7	8.90e-05	62	41	3	C0274861
Disease	Nervous System, Organic Arsenic Poisoning	CD44 UBE2E1 ATXN7	8.90e-05	62	41	3	C0274862
Disease	Dermatologic disorders	CD44 UBE2E1 ATXN7	1.57e-04	75	41	3	C0037274
Disease	N-acetylmethionine measurement	ALMS1 MICAL2	1.96e-04	15	41	2	EFO_0021427
Disease	childhood aggressive behaviour measurement	EPHB6 TNRC18 FCHO2	2.60e-04	89	41	3	EFO_0007663
Disease	serum IgG measurement	FCHO2 AFF3	2.84e-04	18	41	2	EFO_0004565
Disease	type 2 diabetes mellitus (implicated_via_orthology)	IRS1 ALMS1 AFF3	4.23e-04	105	41	3	DOID:9352 (implicated_via_orthology)
Disease	aggressive behaviour measurement, childhood aggressive behaviour measurement	PHLPP1 MICAL2	9.10e-04	32	41	2	EFO_0007663, EFO_0007826
Disease	factor VIII measurement, venous thromboembolism	DGKZ FCHO2	1.03e-03	34	41	2	EFO_0004286, EFO_0004630
Disease	chronic kidney disease, diabetic nephropathy	MLLT3 AFF3	1.15e-03	36	41	2	EFO_0000401, EFO_0003884
Disease	autism spectrum disorder (implicated_via_orthology)	CHD9 ARID1B LRFN2	1.24e-03	152	41	3	DOID:0060041 (implicated_via_orthology)
Disease	Gastric Adenocarcinoma	BRD2 BRDT	1.80e-03	45	41	2	C0278701
Disease	schizophrenia, anorexia nervosa	DGKZ ALMS1	2.04e-03	48	41	2	MONDO_0005090, MONDO_0005351
Disease	hematocrit	MLLT3 ARID1B NFE2L1 HDGFL2 RAI1 AFF3	2.57e-03	1011	41	6	EFO_0004348
Disease	non-high density lipoprotein cholesterol measurement	DGKZ FOXN3 LRFN2 HDGFL2 RAI1	2.96e-03	713	41	5	EFO_0005689
Disease	venous thromboembolism, fibrinogen measurement	CHD9 DGKZ	3.93e-03	67	41	2	EFO_0004286, EFO_0004623

Protein segments in the cluster

Peptide	Gene	Start	Entry
SSSSGSSSSSSDSES	AFF3	416	P51826
RLSESSSSSSSSSES	BRDT	636	Q58F21
SSSESESSSSDLSSS	BRDT	646	Q58F21
SLSDGSDSESSSASS	MLLT3	446	P42568
DSSSSSSLTSSSSAR	FCHO2	436	Q0JRZ9
SSDSISSSASSFLSS	ALMS1	3856	Q8TCU4
SSSSAAAAAASSSSS	ARID1B	121	Q8NFD5
ASATSAASAASSSSS	AHDC1	1076	Q5TGY3
DSTSRFSSSTEQSSA	DVL3	196	Q92997
SSSSASSSASSSFSE	NFE2L1	506	Q14494
ASSSSSSSSFSLDAA	RAI1	1631	Q7Z5J4
SSDSRSSSSSAASDT	RBM15	866	Q96T37
PASSSSSSSSSSAAD	LZTS2	186	Q9BRK4
SSSRDSSSSTSSSSE	PNN	616	Q9H307
SSSSTSSSSESRSRS	PNN	621	Q9H307
SSSVASASSDSSSSS	CSNKA2IP	626	A0A1B0GTH6
AATADDSSSSTSSDS	IRS1	801	P35568
SSSSSSSSHSMESFR	ATXN7	721	O15265
ARSASSSSSSSSSSD	HDGFL2	251	Q7Z4V5
HKSSSSSSSSSSDSD	PPIG	191	Q13427
AERSFHSSSSSSSSS	HSPB7	11	Q9UBY9
SSSSESSSSSSESSA	ARHGAP33	686	O14559
SSDSDSDSERSSCSS	CHD9	2131	Q3L8U1
SDSERSSCSSRSSSS	CHD9	2136	Q3L8U1
DEASSSSSSSSSSSE	BCL6B	231	Q8N143
SSALLDSSSSSSSSS	E2F4	301	Q16254
CDSSSDSKSSSSSSS	EAF2	176	Q96CJ1
DSKSSSSSSSEDSSS	EAF2	181	Q96CJ1
DDVSSGSSSERSSTS	CD44	176	P16070
EDSSSERSSCTSSST	FAM193B	391	Q96PV7
SDRTTSRTSSSSSSD	DBNDD2	206	Q9BQY9
TSDSISSSSSSADDH	FOXN3	351	O00409
RSSDSESASASSSGS	DGKZ	11	Q13574
ASSSASSTSSSSADE	MICAL2	1751	O94851
HRSTSADSASSSDTS	SRRM2	261	Q9UQ35
SSSSSASASSASAAA	NKX6-1	126	P78426
DESFPSSSSSSSSSS	EPHB6	161	O15197
RSSSDSESSSSSSSS	BRPF1	996	P55201
SESSSSSSSSAASDR	BRPF1	1001	P55201
VSRLSASSSSSDSSS	BRD2	771	P25440
ESESSSSSSSGSSSS	TNRC18	2556	O15417
SSASSSSSSSAKARA	MEX3A	406	A1L020
SSSRDTSSSESEQSS	WDR70	96	Q9NW82
SSSSSSDSSASDSSS	ZCCHC10	111	Q8TBK6
SASSTTSSSSSDSDS	ZCCHC10	151	Q8TBK6
SAAAAAASSSSSSSA	PHLPP1	131	O60346
MSDDDSRASTSSSSS	UBE2E1	1	P51965
FTASLARASDSSSSS	LRFN2	611	Q9ULH4